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Prior work has shown that the neurotrophin, brain-derived neurotrophic factor (BDNF), fosters 
adaptive plasticity within the spinal cord. To be clinically useful, BDNF must be applied over 
extended periods of time (days to weeks). The present proposal evaluated whether this can be 
accomplished using a hydrogel containing BDNF. Using in vitro procedures, a hydrogel was 
developed that slowly releases BDNF over a one-week period. We tested the effectiveness of this 
hydrogel in vivo. The impact of drug treatment was assessed by testing its effect on mechanical 
reactivity and spinal learning. Spinally transected rats had the BDNF-containing hydrogel 
applied over the lumbosacral spinal cord. Subjects were tested 3-24 hrs later. Prior work has 
shown that BDNF enhances learning (adaptive plasticity) without affecting mechanical reactivity 
(a form of maladaptive plasticity indicative of enhanced pain).  I found that BDNF applied using 
a hydrogel fostered adaptive plastic without affecting mechanical reactivity. This work provides 
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BDNF    Brain Derived Neurotrophic Factor 
SCI    Spinal Cord Injury 
T2    Second Thoracic Vertebra 
L3    Third Lumbar Vertebra  
S1    First Sacral Vertebra  
i.p.    Intraperitoneal Injection 
HA    Hyaluronic Acid  
MC     Methylcellulose  















Neurotrophins are a group of proteins associated with growth, development and functioning of 
neurons. The current proposal focuses on the neurotrophin brain-derived neurotrophic factor 
(BDNF), which is found in the central nervous system and periphery and is associated with 
neural growth. BDNF is responsible for survival of existing neurons as well as the development 
and differentiation of new neurons. BDNF is also responsible for regulation of learning and 
memory within the brain and encourages the development of long-term potentiation (LTP) (Kang 
& Schumann, 1995).  BDNF plays a vital role in spatial memory (Mizuno et al., 2000). BDNF is 
vital to normal nerve growth and mice born unable to produce BDNF suffer from brain defects 
and die shortly after birth (Enfors, 1995). BDNF has also been shown to promote neural 
plasticity within the brain (Cohen, 2012.). Here, I explore a procedure designed to apply BDNF 
over extended periods with the aim of fostering adaptive plasticity within the spinal cord. 
 
Prior work has shown that acute treatment with BDNF can foster adaptive plasticity within the 
spinal cord (Huie et al., 2012). With the use of an in vivo model system it was demonstrated that 
training with controllable stimulation (shock that is response dependent) increases spinal BDNF 
expression and engages a BDNF-dependent process that promotes adaptive plasticity as 
evidenced by increased BDNF mRNA expression and protein within the lumbar spinal cord and 
the appearance of a learning deficit (failure to maintain leg flexion to avoid shock) when a 
BDNF inhibitor (TrkB-IgG) was applied (Gómez-Pinilla et al., 2007, Huie et al., 2012). Direct 
(intrathecal) application of BDNF substituted for instrumental training (administration of 
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electrical shock to the hind leg whenever the leg is in an extended position) to block both the 
induction and expression of the learning deficit (Huie et. al, 2012). The ability of BDNF to 
prevent and reverse a typically apparent learning deficit without adverse effects suggests that 
application of BDNF after a spinal injury could promote recovery. Of specific concern, at higher 
doses BDNF can sometimes enhance reactivity to mechanical stimulation (Cejas et al., 2000; 
Coull et al, 2005) causing subjects to exhibit a nociceptive (pain) reflex to moderate cutaneous 
stimulation (a form of maladaptive plasticity known as allodynia). However, Huie et al. (2012) 
found BDNF prevented shock-induced allodynia in spinally transected rats. Therefore, BDNF is 
a prime candidate to promote adaptive plasticity within the spinal cord but in large doses BDNF 
overpromotes plasticity causing an adverse effect in the form of allodynia.  
 
Researchers have also explored the possibility that BDNF treatment can foster recovery after a 
spinal contusion injury. While a transection cuts the spinal tissue, a contusion injury provides a 
bruising that better emulates a typical human injury. While studies examining the impact of 
BDNF on spinal function after injury have reported some positive effects, such as enhanced 
neuron excitability, promoting recovery of locomotor function, difficulties have been 
encountered, including increased spasticity and heightened pain (Boyce et al., 2012). Also of 
particular concern, BDNF is extremely expensive ($50,000 per a gram). Moreover, to be 
clinically useful, the neurotrophin must be applied for extended periods of time (days to weeks) 
at a concentration that does not have an adverse effect. To address these limitations, a targeted 
drug delivery platform that allows drug delivery to the injured site is needed. Ideally this drug 




Bioengineered hydrogels may provide a useful technique for the local administration of BDNF 
over extended durations. Many hydrogels have been developed with the goal of direct drug 
delivery. Natural hydrogels are preferable for their similarity to the living tissue in which they 
are to be injected. Hyaluronic Acid (HA) is a commonly used natural material that can be highly 
tailored, allowing for the controlled release of drug depending on how it is encapsulated. The 
ability to modify the release profile of the hydrogel allows for a better evaluation of the effect of 
the drug of interest. Previous work has shown that HA and methyl cellulose (MC) can be used as 
an intrathecal delivery (Gupta et al., 2006; Kang et al., 2009). 
 
My project evaluated whether BDNF can be applied using a hydrogel that slowly releases BDNF 
at a concentration that should foster adaptive plasticity without inducing behavioral signs of 
allodynia. Previous studies delivering BDNF showed positive results but also had adverse 
effects, we sought to determine whether a hydrogel could be used as a platform to acutely 
administer BDNF to the injury site without negative effects. Working with bioengineers at the 
University of Florida at Gainesville, FL, a hydrogel composed of HA and MC was developed 
that slowly releases BDNF in vitro.  The HAMC hydrogel was shown to slowly deliver 
encapsulated BDNF in vitro, with all encapsulated BDNF released after 16.5 hours.  
 
My study explored whether a BDNF-containing hydrogel could be used to promote adaptive 
plasticity within the spinal cord by the facilitation of learning of an instrumental task at a 
criterion in which naïve rats fail to learn. This was accomplished using the spinal learning 
procedure described by Huie et al. (2012), in which spinally transected rats are tested using an 
instrumental learning procedure. Rats that have undergone a thoracic spinal transection received 
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leg shock whenever one hind limb is extended. Over time, subjects learn to maintain the shocked 
leg in a flexed position that minimizes net shock exposure. Huie et al. showed that a low dose of 
BDNF fosters learning in this paradigm without inducing signs of allodynia. My aim was to test 
whether the drug is effective when applied using a hydrogel. A BDNF containing hydrogel was 
applied over the lumbosacral spinal cord at the time of surgery as this area has shown to be the 
locus of learning (Joynes et al., 2004). The onset and duration of drug treatment was then 
evaluated from from 3-24 hrs after surgery to establish the effectiveness of BDNF gel in vivo.  
We expect to find that at a higher response criterion BDNF will facilitate learning for the 
instrumental learning task indicating its ability to promote plasticity and be potentially used for 







Subjects were adult male Sprague-Dawley acquired from Harlan labs in Houston, TX. All 
subjects were approximately 100-120 days old and weighed between 350-450 g. The subjects 
were housed in individual cages and were kept on a 12 hour light and dark cycle. All behavioral 
testing was performed during the light period. Food and water were available ad libitum. This 
4 (time) by 2 (drug+gel or gel only) design required 48 Sprague-Dawley rats (n= 6).   
 
Surgery 
Surgery was performed with isoflurane as the anesthetic. The subjects’ head was immobilized by 
a stereotaxic apparatus. A small gauze pillow was placed under the subject’s chest to provide 
support for breathing. The second thoracic vertebra (T2) was located by feel and an incision 
made anterior to posterior. The tissue above T2 was cleared away using rongeurs until the spinal 
cord was visible. Subjects were spinally transected at T2 using a cautery tool. Closure of the 
incision site was done using Michel clips (Fine Science Tools, Foster, CA).  Another anterior-
posterior incision was made above the L3/S1 region. Using rongeurs the tissue surrounding the 
vertebrae was cleared.  A laminectomy, in which vertebrae is removed leaving the spinal cord 
exposed, was performed over the L3/S1 area. Thermally set BDNF hydrogel or gel containing no 





Figure 1. Procedure for HAMC Hydrogel Application onto the Spinal Cord. 
	  	  
Figure 1. Procedure for HAMC Hydrogel Application onto the Spinal Cord. Method of 
delivering BDNF into the intrathecal space using an injectable HA-based hydrogel. Figure 
adapted from (Baumann et al 2009). 
 
The incision site was closed with Michel Clips. Subjects then had each leg shaved for electrode 
placement. Subjects were given a 3 mL i.p. injection of 0.9% saline solution to maintain 
hydration. Subjects’ legs were kept in a fixed position immediately after surgery until testing 
with the assistance of porous orthaletic tape, gently wrapped around the rat’s body. Subjects 
were placed in a temperature controlled environment until testing occurred. Subjects’ bladders 
were expressed as needed and immediately before testing.  
 
Mechanical Reactivity 
Prior to instrumental testing, mechanical reactivity was assessed using von Frey stimuli. Subjects 
were placed in a Plexiglas tube with hind legs exposed and freely hanging. Sensitization was 
examined by the pressing of Von Frey filaments into the mid plantar portion of the hind paw. 
Filaments were presented with increasing intensity until a flexion response was produced. The 





Instrumental Learning Apparatus and Procedure 
Independent groups were tested 3, 6, 12, and 24 hours after surgery. Subjects then received 30 
minutes of testing in our instrumental learning paradigm with the underlying saline solution level 
set to a high (8mm) response criterion (for a detailed description of the test apparatus and 
procedure see figure below as well as Huie et al., 2012). Flexion duration was recorded by the 
time in which the electrode did not make contact with the solution.  
 
Figure 2. Instrumental Learning Paradigm. 
 
Figure 2. Instrumental Learning Paradigm. The apparatus used to evaluate instrumental learning 
(from Grau et al., 1998). 
 
Statistics 
All data were analyzed using repeated measures analysis of variance (ANOVA). An alpha value 
of .05 or below was considered statistically significant. Differences between group means were 






Subjects underwent 30 min of testing with a high response criterion at which naïve rats typically 
fail. In this paradigm, learning brings about an increase in flexion duration that minimizes net 
shock exposure. When tested with a high response criterion, vehicle treated rats typically fail to 
learn (and do not exhibit an increase in flexion duration). The key question is whether the 
BDNF-containing hydrogel would allow learning. As shown in Figure 3A, vehicle treated rats 
failed to learn when tested 3, 6, 12, and 24 hrs after surgery. BDNF-treated rats showed superior 
learning and this effect was most evident 12 hrs after treatment (Figure 3B). Statistical analyses 
confirmed that the main effects of time point and drug on response number were significant, all 
F(3,87)= 3.42, p < .05. The BDNF gel 12 hour time point performed significantly better for the 
instrumental learning task (p< .05).  A post-hoc comparison of response duration means across 
groups showed that 12-hour BDNF gel (M= 40.65 SD= 26.86) differed significantly from the 12-
hour gel only group (M= 3.24, SD= 11.06). No other group differences were significant (p> .05). 
 



























Figure 3. Response Duration for Instrumental Learning Task after BDNF Application. (A) Gel 
administered without BDNF did not facilitate learning. (B) Facilitation of learning was greatest 
at 12 hours after BDNF application.  
 
A failure to learn could, potentially, reflect a performance deficit. To address this possibility, I 
also examined response number. Under normal circumstances, subjects that fail to learn make 
the highest number of responses; the repeatedly experience a flexion-eliciting shock, but this 
shock fails to produce an increase in flexion duration. This was observed in the present 
experiment (see Figure 4), where I found that subjects given just gel are able to respond but do 
not maintain this flexion (Figure 4A).  BDNF- treated rats demonstrated lower response numbers 
indicating flexion occurred and was maintained longer than their control counterparts. Statistical 
analyses confirmed that response number for the 12-hour BDNF group was significantly 
different with all F(3,87)=.77, p<.05. The 12-hour BDNF gel group displayed a significantly 
















Figure 4B. Response Number with BDNF 
	   
Figure 4. Response Number for Instrumental Learning Task after BDNF Application. (A) The 
flexion response was observed in the gel only group but this response was not maintained as 
demonstrated by the higher numbers (B) BDNF gel facilitated learning at 12 hours as 
demonstrated by lower response number indicative of maintained flexion.  
 
The impact of drug treatment on mechanical reactivity is illustrated in Figure 5. I found that drug 
had no effect between treatment groups. An ANOVA demonstrated a main effect of time on 
mechanical reactivity with a statistically significant difference between the 6 hour groups and all 
other time points, all F(1,3)= 1.03, p <.05. Within subjects there was no change from baseline 
before and after instrumental testing. No other comparisons were significant (p > .05). 
 
 


































Figure 5. Mechanical Reactivity Threshold 
 
Figure 5. Effect of BDNF Application on mechanical reactivity. There was no significant 















































Spinally transected rats who received acutely administered BDNF hydrogel displayed enhanced 
learning, as demonstrated by the increased flexion duration under a higher response criterion for 
the instrumental learning paradigm. The greatest increase in learning occurred at the twelve hour 
time point but the hydrogel was still visible 24 hours after application. BDNF has been shown to 
assist in recovery of function after spinal cord injury. The effect of BDNF was apparent at the 12 
hours post application but nonexistent at 24 hours post application. Although the hydrogel was 
able to positively affect learning, this effect did not occur as quickly as we anticipated as 
demonstrated by unapparent difference between the BDNF and gel only groups at the 3 hour, 6 
hour and 24-hour mark. The slow onset and short duration of the drug effect are both concerns 
that future studies will potentially address by manipulating concentrations of BDNF as well as 
adjusting the manner in which BDNF is encapsulated.  
 
BDNF facilitated learning as indicated by the increase in flexion duration. Coinciding with these 
findings response number decreased in the group in which facilitation occurred (12 hour BDNF 
gel). If learning is occurring response number decreases because the ability to maintain flexion is 
indicative of the ability to acquire the learning task. These findings are supported by previous 





Coinciding with previous studies done by Huie et.al 2012 the dosage of .4µg BDNF 
administered did not induce mechanical allodynia. This is consistent with other recent work from 
our laboratory indicating that BDNF has an anti-allodynic effect in spinally transected rats. The 
hydrogel BDNF was able to deliver the benefits seen without adverse effect. BDNF’s ability to 
increase neuron excitability and promote plasticity makes it a protein of interest for future studies 
trying to examine drug therapies for injury within the nervous system, specifically SCI. The 
ability to directly administer drug to the site of injury minimizes potential possible negative 
effect to surrounding tissues or systems and also allows for targeted, concentrated drug delivery.  
 
Further research will look at drug effectiveness over a longer time frame, as well as the effect of 
high and low concentrations of BDNF on learning. Future studies will try to establish a more 
effective means of eliciting the drug effect at a time point sooner than 12 hours. To be clinically 
useful BDNF should be applied over extended periods of time (days to weeks), so future studies 
will look at how to elicit this drug effect sooner and how to maintain this effect for much longer 
duration. They will do so by varying encapsulation techniques to explore how to prolong drug 
delivery so that the effect is maintained for a longer period of time.  
 
The long-term goal is to establish an effective treatment drug delivery platform to be used after a 
contusion injury to help enhance recovery of locomotor function. We hope to identify an ideal 
drug concentration to accomplish this and will do so by testing several concentrations of BDNF. 
By the end of the BDNF hydrogel experiments, we hope to determine an effective and efficient 
way to combine BDNF and behavioral training to improve recovery after SCI. Ultimately these 
findings will provide the foundation for an injectable drug delivery platform that would allow for 
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targeted, long-term release of therapeutics to the affected tissue, circumventing the blood brain 
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